Laserfiche WebLink
The remainiig physicochemistry parameters remained relatively the same, less then 10% <br /> change over the period of the study (see Exhibit 1), as would be expected since the <br /> uptake of nitrate is the easiest process for the microbes which will later utilize the other <br /> parameters when nitrate levels become limiting Over the course of the study nitrate <br /> levels dropped 29% from baseline, while the general population increased 20% at T=14 <br /> and the selective counts increased 76 fold, resulting in an increase of 76 fold in overall <br /> degrader kinetics for the study <br /> Conclusions and Recommendations <br /> Based on the correlation and evaluation of all of the bench scale laboratory results <br /> collected, the data certainly indicates that a stimulatory bioremedial approach would be a <br /> viable option for site mitigation based on the parameters evaluated in this investigation <br /> Both the nutrient and oxygen augmentation provided similar results, however the nutrient <br /> augmentation study provided a larger increase in selective microbial counts Should a <br /> bioremedial approach be desired for this site, it would be BioJet's opinion to initially <br /> implement nutrient augmentation field treatability in a designated area(s) to establish <br /> injection and monitoring parameters to ensure otological and regulatory site specific <br /> objectives are achieved and mamtained prior to full scale implementation Physical site <br /> conditions should also be evaluated and taken into consideration <br /> Upon AES's review of this report BioJet personnel would be happy to discuss in detail a <br /> design and implementation for field activities <br /> Biologic would like to thank AES for the opportunity to perforin this investigation, and <br /> look forward to discussing this report and providing any assistance necessary in <br /> facilitating your remediation needs Should you have any questions, please feel free to <br /> call anytime at (209) 245-6044 <br /> Respectfully <br /> Ken Farrar <br /> BioJet, Inc <br />